Optimizing survival in advanced prostate cancer: Understanding PC heterogeneity to guide treatment choices
29 Jan 2015
Optimizing survival in advanced prostate cancer: Understanding PC heterogeneity to guide treatment choices
Optimizing survival in advanced prostate cancer: Welcome and introduction
Optimizing survival in advanced prostate cancer: Tailoring mCRPC therapies to optimise survival
Optimizing Survival in Advanced Prostate Cancer: Conclusion
Cancer cell models for improved therapies
UICC 2014 conference report
Comment: SABCS 2014 Highlights
Comment: Multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ
CLL at ASH 2014: Expert discussion
Best of ASH 2014
ASH 2014: Highlights in CLL from ASH 2014
ASH 2014: Highlights in mantle cell lymphoma